Abstract
Clinical signs of corticospinal tract dysfunction are a common feature of spinocerebellar ataxia type 2 (SCA2) patients. The objective of this study is to assess dysfunction of the corticospinal tract in SCA2 using corticomuscular coherence. Testing corticomuscular coherence and rating of ataxia severity and non-ataxia symptoms were performed in 19 SCA2 patients and 24 age-matched controls. Central motor conduction times (CMCT) to upper and lower right limbs were obtained for the SCA2 group using Transcraneal magnetic stimulation (TMS). SCA2 patients exhibited a significant reduction of corticomuscular coherence for lower limbs, but not for upper limbs. This difference remained significant, even when excluding those individuals with clinical signs of corticospinal tract dysfunction. Corticomuscular coherence for lower limbs correlated inversely with CMCT to tibialis anterior muscle. Corticomuscular coherence could be a valuable electrophysiological tool to assess the corticospinal tract involvement in SCA2, even in the absence of clinical signs of corticospinal tract dysfunction.
References
Auburger GW. Spinocerebellar ataxia type 2. Handb Clin Neurol. 2012;103:423–36.
Satterfield TF, Jackson SM, Pallanck LJ. A Drosophila homolog of the polyglutamine disease gene SCA2 is a dosage-sensitive regulator of actin filament formation. Genetics. 2002;162(4):1687–702.
van den Heuvel DM, Harschnitz O, van den Berg LH, Pasterkamp RJ. Taking a risk: a therapeutic focus on ataxin-2 in amyotrophic lateral sclerosis? Trends Mol Med. 2014;20(1):25–35.
Velázquez-Pérez L, Rodríguez-Labrada R, Canales-Ochoa N, et al. Progression of early features of spinocerebellar ataxia type 2 in individuals at risk: a longitudinal study. Lancet Neurol. 2014;13(5):482–9.
Velázquez-Pérez L, Rodríguez-Labrada R, Cruz-Rivas EM, et al. Comprehensive study of early features in spinocerebellar ataxia 2: delineating the prodromal stage of the disease. Cerebellum. 2014;13(5):568–79.
Farmer SF, Bremner FD, Halliday DM, Rosenberg JR, Stephens JA. The frequency content of common synaptic inputs to motoneurones studied during voluntary isometric contraction in man. J Physiol (Lond). 1993;470:127–55.
Ushiyama J, Takahashi Y, Ushiba J. Muscle dependency of corticomuscular coherence in upper and lower limb muscles and training-related alterations in ballet dancers and weightlifters. J Appl Physiol (1985). 2010;109(4):1086–95.
Caviness JN, Shill HA, Sabbagh MN, Evidente VG, Hernandez JL, Adler CH. Corticomuscular coherence is increased in the small postural tremor of Parkinson’s disease. Mov Disord. 2006;21(4):492–9.
Jung KY, Cho JH, Ko D, et al. Increased Corticomuscular Coherence in Idiopathic REM Sleep Behavior Disorder. Front Neurol. 2012;3:60. doi:10.3389/fneur.2012.00060.eCollection2012.
von Carlowitz-Ghori K, Bayraktaroglu Z, Hohlefeld FU, Losch F, Curio G, Nikulin VV. Corticomuscular coherence in acute and chronic stroke. Clin Neurophysiol. 2014;125:1182–91.
Schmitz-Hübsch T, du Montcel ST, Baliko L, et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology. 2006;66:1717–20.
Schmitz-Hübsch T, Coudert M, Bauer P, et al. Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms. Neurology. 2008;71:982–9.
Oostenveld R, Fries P, Maris E, Schoffelen JM. FieldTrip: Open source software for advanced analysis of MEG, EEG, and invasive electrophysiological data. Comput Intell Neurosci. 2011;2011:156869.
McClelland VM, Cvetkovic Z, Mills KR. Rectification of the EMG is an unnecessary and inappropriate step in the calculation of Corticomuscular coherence. J Neurosci Methods. 2012;205(1):190–201.
Maris E, Oostenveld R. Nonparametric statistical testing of EEG- and MEG-data. J Neurosci Methods. 2007;164:177–90.
Fisher KM, Zaaimi B, Williams TL, Baker SN, Baker MR. Beta-band intermuscular coherence: a novel biomarker of upper motor neuron dysfunction in motor neuron disease. Brain. 2012;135:2849–64.
Velazquez-Perez L, Rodriguez-Labrada R, Torres-Vega R, et al. Central motor conduction time as prodromal biomarker in spinocerebellar ataxia type 2. Mov Disord. 2016;31(4):603–4.
Velazquez-Perez L, Rodriguez-Labrada R, Torres-Vega R, et al. Abnormal corticospinal tract function and motor cortex excitability in non-ataxic SCA2 mutation carriers: a TMS study. Clin Neurophysiol. 2016;127:2713–9.
Robinson IR, Janton P, McLean IC. Central motor conduction times using transcranial magnetic stimulation and F waves latencies. Muscle Nerve. 1988;11:174–80.
Seidel K, Siswanto S, Brunt ER, den Dunnen W, Korf HW, Rüb U. Brain pathology of spinocerebellar ataxias. Acta Neuropathol. 2012;124(1):1–21.
Kuypers H. The anatomical organization of the descending pathways and their contributions to motor control especially in primates. In: Desmedt JE, ed. New developments in electromyography and clinical neuro-physiology, vol. 3 Basel: Karger 1973: 38–68.
Restivo DA, Giuffrida S, Rapisarda G, Antonuzzo A, Saponara R, Reggio A, et al. Central motor conduction to lower limb after transcranial magnetic stimulation in spinocerebellar ataxia type 2 (SCA2). Clin Neurophysiol. 2000;111(4):630–5.
Rossini PM, Caramia MD. Methodological and physiological considerations on the electric or magnetic transcranial stimulation. In: Rossini PM, Marsden CD, editors. Non-invasive stimulation of brain and spinal cord: fundamentals and clinical applications. New York: Alan R. Liss; 1988. p. 37–65.
Elden AC, Kim HJ, Hart MP, Chen-Plotkin AS, Johnson BS, Fang X, et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature. 2010;466:1069–75.
Acknowledgments
We are grateful to the SCA2 patients and the healthy controls for their participation. This work was funded by the Alexander von Humboldt Foundation and the Cuban Ministry of Public Health, and it was carried out while Prof. Luis Velázquez-Pérez was the recipient of the Georg Forster Research Award from the Alexander von Humboldt Foundation.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
This study was approved by the institutional ethics committee and was conducted according to the Declaration of Helsinki.
Conflict of Interest
The authors declare that they have no conflict of interest.
Funding Statement
This work was funded by the Alexander von Humboldt Foundation and the Cuban Ministry of Public Health, and it was carried out while Prof. Luis Velázquez-Pérez was the recipient of a Georg Forster Research Award from the Alexander von Humboldt Foundation.
Rights and permissions
About this article
Cite this article
Velázquez-Pérez, L., Tünnerhoff, J., Rodríguez-Labrada, R. et al. Corticomuscular Coherence: a Novel Tool to Assess the Pyramidal Tract Dysfunction in Spinocerebellar Ataxia Type 2. Cerebellum 16, 602–606 (2017). https://doi.org/10.1007/s12311-016-0827-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12311-016-0827-4